EMA Clinical Trials Map Visualizer Explained

Explore how the EMA Clinical Trials Map visualizes trial activity across Europe to support recruitment planning and site strategy decisions.

EMA Clinical Trials Map Visualizer Explained

Explore how the EMA Clinical Trials Map visualizes trial activity across Europe to support recruitment planning and site strategy decisions.
Cyntegrity logo – Risk-Based Quality Management Solutions

Seeing Clinical Trial Activity in Context

Clinical trial data is widely available, yet not always easy to interpret when geography plays a central role. Tables and spreadsheets are effective for calculations, but they often obscure spatial patterns that matter for planning and oversight.

 

The EMA Clinical Trials Map Visualizer addresses this gap by presenting European clinical trial data in a geographic format. It helps clinical operations and analytics teams understand where trials are concentrated, which regions are actively recruiting, and how competition for sites may affect feasibility and timelines.

What You Can Do With the Visualizer

Turn geographic data into operational awareness.

Explore trial distribution across Europe

View trial and site density at country, regional, and sub-regional levels to understand where research activity is concentrated.

Filter by medical condition and recruitment status

Narrow results by indication and active recruitment to assess competition, site experience, and feasibility for upcoming studies.

Support recruitment and site strategy decisions

Use geographic patterns to anticipate site availability, investigator workload, and potential overlap with other trials.

Why a map changes how data is understood

The visualizer is built on publicly available EMA clinical trial registry data. Instead of listing trials in tabular form, it displays them geographically, allowing users to see relationships between location, study volume, and recruitment activity at a glance.

 

This visual approach reduces analytical friction and supports earlier, more informed decisions—particularly when planning studies in regions with varying site capacity or competing trials.

What changes when you view trial data on a map instead of a table?
Explore how geographic context reveals patterns that are difficult to detect through spreadsheets alone.

Part of the eyesON Interactive Visualizer Series

The EMA Clinical Trials Map Visualizer is part of Cyntegrity’s eyesON series—a collection of free, interactive tools designed to make complex clinical research data easier to explore and interpret.

 

Through eyesON, Cyntegrity shares its data analytics expertise with the broader research community, helping teams build intuition around regulatory, operational, and methodological topics without adding complexity. Explore More Interactive Visualizers…

Explore The EMA Visualizer

See how other datasets can sharpen signal awareness and decision-making.

Stay Informed with Us

Explainable AI in Clinical Trials

Clinical trial AI should do more than detect patterns. It must help teams understand, challenge, and document the rationale behind risk signals. Cyntegrity’s latest research reference explores how explainable mathematical discovery can support the next generation of RBQM innovation....

RBQM Explained: Why 100% SDV Falls Short in Clinical Trials

An educational excerpt from MyRBQM Essentials White Belt explaining why traditional monitoring and 100% Source Data Verification are no longer enough for modern clinical trial oversight....

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

What Is the Financial Value of RBQM?

Download the updated case study with 2026 Tufts CSDD insights
and Cyntegrity’s operational value perspective.